NASDAQ$EHTH
eHealth Inc · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Delivered strong Medicare enrollment and revenue growth with substantial improvement in profitability metrics.
eHealth's Q4 2023 results reflect the success of their transformation program and AEP preparedness efforts, with a 26% YoY revenue increase driven by strong Medicare enrollment growth and improved profitability metrics. The company's operating cash flow exceeded expectations due to favorable retention trends in the Medicare book of business.
- Q4 2023 total revenue increased 26% year-over-year to $247.7 million.
- Medicare Advantage approved members increased 22% year-over-year.
- Medicare Advantage LTV increased 11% year-over-year to $1,151.
- GAAP net income improved $31.5 million year-over-year to $52.2 million.
Headline financials
Revenue & EPS history
eHealth · Revenue · Quarterly
$248M
Revenue by segment
eHealth · $64.7M total across 2 segments · Q3 2023
- Medicare$55.5M+23.0%85.8%
- Employer and Individual$9.2M—14.2%
Forward guidance
eHealth provides guidance for the full year ending December 31, 2024, with total revenue expected to be in the range of $450 million to $475 million, GAAP net loss expected to be in the range of $(40) million to $(20) million, adjusted EBITDA expected to be in the range of $(5) million to $20 million, and operating cash flow expected to be in the range of $(15) million to $(5) million.
Tailwinds
- Total revenue is expected to be in the range of $450 million to $475 million.
- GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.
- Adjusted EBITDA(1) is expected to be in the range of $(5) million to $20 million.
- Operating cash flow is expected to be in the range of $(15) million to $(5) million.
- Excluding the impact of positive net adjustment revenue in both years, the mid-point of our 2024 guidance reflects approximately 12% year-over-year total revenue growth and a substantial improvement in GAAP net income (loss) and adjusted EBITDA(1).
Headwinds
- Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth’s annual and quarterly reports filed with the Securities and Exchange Commission.
- The above guidance includes the expected impact of positive net adjustment revenue in the range of $0 to $15 million.
- GAAP net income (loss) is expected to be in the range of $(40) million to $(20) million.
- Adjusted EBITDA(1) is expected to be in the range of $(5) million to $20 million.
- Operating cash flow is expected to be in the range of $(15) million to $(5) million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
-1.0%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.6%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+25.2%
Q3 2022
Best reaction
-34.3%
Q2 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | -7.1% | -12.7% | |
| Q4 2025 | -30.7% | -17.5% | -32.3% | |
| Q3 2025 | -21.8% | -16.2% | -22.9% | |
| Q1 2025 | +23.2% | +19.2% | -8.1% | |
| Q4 2024 | +3.3% | -5.7% | -28.2% | |
| Q3 2024 | +9.2% | +3.5% | +12.2% | |
| Q2 2024 | -12.8% | -7.7% | -18.8% | |
| Q1 2024 | +12.4% | +8.2% | +9.4% | |
| Q4 2023 | -8.2% | -7.1% | -14.6% | |
| Q3 2023 | -8.5% | -11.7% | +2.1% | |
| Q2 2023 | -0.1% | -1.1% | -14.2% | |
| Q1 2023 | +15.1% | +8.2% | +49.1% | |
| Q4 2022 | -8.4% | +2.5% | +5.4% | |
| Q3 2022 | +25.2% | +27.8% | +47.4% | |
| Q2 2022 | -2.7% | +16.8% | -32.2% | |
| Q1 2022 | +22.5% | +31.1% | +31.1% | |
| Q4 2021 | -16.7% | -25.5% | -20.1% | |
| Q3 2021 | -25.8% | -30.7% | -35.2% | |
| Q2 2021 | -5.9% | -9.3% | -28.6% | |
| Q1 2021 | -0.7% | -5.2% | -8.4% | |
| Q4 2020 | +5.9% | +6.6% | +19.4% | |
| Q3 2020 | -6.8% | -8.2% | -8.7% | |
| Q2 2020 | -31.1% | -36.9% | -40.3% | |
| Q1 2020 | -8.1% | -7.1% | +12.4% | |
| Q4 2019 | -0.6% | -13.7% | -22.3% | |
| Q3 2019 | +0.2% | +10.8% | +39.3% | |
| Q2 2019 | +24.8% | +21.5% | +10.5% | |
| Q1 2019 | +3.7% | -2.0% | +4.3% | |
| Q4 2018 | -3.6% | -7.2% | -4.9% | |
| Q3 2018 | +13.2% | +15.2% | +23.0% | |
| Q2 2018 | -3.6% | -1.2% | +24.6% | |
| Q1 2018 | +17.3% | +21.6% | +31.9% | |
| Q4 2017 | -16.2% | -4.1% | -12.2% | |
| Q3 2017 | +7.0% | +15.3% | +3.5% | |
| Q2 2017 | -5.3% | -8.3% | +23.3% | |
| Q1 2017 | +23.2% | +39.6% | +59.9% | |
| Q4 2016 | +8.9% | +6.3% | +2.5% | |
| Q3 2016 | -31.8% | -30.2% | -5.6% | |
| Q2 2016 | -29.4% | -32.2% | -18.6% | |
| Q1 2016 | +23.2% | — | — | |
| Q4 2015 | +0.7% | — | — | |
| Q3 2015 | -4.2% | — | — | |
| Q2 2015 | +21.4% | — | — | |
| Q1 2015 | +13.5% | — | — | |
| Q4 2014 | -3.6% | — | — | |
| Q3 2014 | +15.4% | — | — | |
| Q2 2014 | -34.3% | — | — | |
| Q1 2014 | -12.3% | — | — | |
| Q4 2013 | -8.5% | — | — | |
| Q3 2013 | +9.6% | — | — | |
| Q2 2013 | -1.8% | — | — | |
| Q1 2013 | +7.3% | — | — | |
| Q4 2012 | -22.8% | — | — | |
| Q3 2012 | +9.5% | — | — | |
| Q4 2011 | -1.1% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q3 2010 | -3.1% | — | — | |
| Q3 2011 | -3.1% | — | — | |
| Q4 2010 | -7.0% | — | — | |
| Q2 2011 | -7.0% | — | — | |
| Q2 2010 | -7.0% | — | — | |
| Q1 2010 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro